Updated Perspecives, Laboratory Considerations, and Clinical Implications
Webinar #9: Immunoglobulin and T-cell receptor gene sequencing: Recent Findings, Laboratory Considerations, and Clinical Implicationsĭate: Thursday April 7 at 11:00am EasternĬlick on the links below to access the full webinar(s) or the 15-min microlearning module(s). Webinar #8: Methylation Profiling: Recent Findings, Laboratory Considerations, and Clinical Implicationsĭate: Tuesday January 25th, 2022 at 2:00pm Eastern Webinar #7: KRAS: Recent Findings, Laboratory Considerations, and Clinical Implications Webinar #6: Myeloid Malignancy MRD: Recent Findings, Laboratory Considerations, and Clinical Implications Webinar #5: ERBB2 (HER2) in Colorectal Cancer: Recent findings, laboratory considerations, and clinical implications Webinar #4: NTRK: Updated Perspectives, Laboratory Considerations, and Clinical Implications Webinar #3: METex14: Updated Perspectives, Laboratory Considerations, and Clinical Implications Webinar #2: HRD Score: Updated Perspectives, Laboratory Considerations, and Clinical Implications Webinar #1: MGMT: Updated Perspectives, Laboratory Considerations, and Clinical Implications
A series of short learning modules that can be reviewed based on need and interest in the science, laboratory applications, and/or clinical implications of each marker.
A complete presentation with pre- and post-tests plus available continuing education credit and 2. 15-20 minutes of discussion on the clinical implications of biomarker use.Īfter broadcast, each webinar will be posted on the AMP ED TM online Learning Management System as 1.15-20 minutes covering the laboratory considerations for the testing approach to each biomarker.15-20 minutes of a scientific overview of recent and relevant research on the biomarker.This series will efficiently describe emerging and evolving biomarkers in a series of live webcasts that will be structured to provide a consistent framework in which to consider the application of new information on specific biomarkers. With the range of clinically informative biomarkers, the types of tests to detect these biomarkers, and the resulting clinical implications constantly expanding and becoming more complex, it has become increasingly burdensome for healthcare professionals to keep pace. However, these advancements have also created a highly complex environment for healthcare providers and diagnostic laboratory personnel. The extraordinary advancements made over the past several years in the clinical management of cancer have ushered in a new era of optimism for those afflicted with many cancer types. FEATURED CONTENT: AMP Molecular in a Minute: Micro-learning Modules in Molecular PathologyĮmerging and Evolving Biomarkers: Recent Findings, Laboratory Considerations, and Clinical Implications.FEATURED CONTENT: Utility of Cell-free DNA in the Clinic: Current State and Future Directions.FEATURED CONTENT: Emerging and Evolving Biomarkers Series.